[1] Carr RM, Oranu A, Khungar V.Nonalcoholic fatty liver disease: pathophysiology and management[J]. Gastroenterol Clin North Am, 2016, 45(4):639-652. [2] Karim MF, Al-Mahtab M, Rahman S, et al.Non-alcoholic fatty liver disease (NAFLD) - a review[J]. Mymensingh Med J, 2015, 24(4):873-880. [3] 郎雪楠, 陈雪婷, 董婉维, 等. 芹菜山楂汁对非酒精性脂肪肝模型小鼠血压、血脂、脂肪肝形成的影响[J]. 实验动物与比较医学, 2016, 36(2):134-136. [4] 韩然, 杨丹. p38丝裂原活化蛋白激酶通路在非酒精性脂肪肝中的作用[J].中国医药导报, 2014, 11(36):166-168. [5] Li Y, Yao J, Han C, et al.Quercetin, inflammation and immunity[J]. Nutrients, 2016, 8(3):167. [6] 谢湖均, 雷群芳, 方文军. 槲皮素抗氧化活性的密度泛函理论研究[J]. 化学学报, 2010, 68(15):1467-1472. [7] 邓炜, 冯崇廉, 聂钊源, 等. 疏肝消脂III方胶囊对非酒精性脂肪性肝病大鼠肝组织过氧化物酶体增殖物激活受体γ及脂联素受体2表达的影响[J].中西医结合肝病杂志,2016, 26(2):96-98. [8] Ying HZ, Liu YH, Yu B, et al.Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils[J]. Food Chem Toxicol, 2013, 52(10):53-60. [9] Storniolo A, Raciti M, Cucina A, et al.Quercetin affects Hsp70/IRE1〈 mediated protection from death induced by endoplasmic reticulum stress[J]. Oxid Med Cell Longev, 2015, 2015:645157. [10] 邓丽丽, 臧家娜, 应华忠, 等. 热休克蛋白70在兔非酒精性脂肪肝纤维化过程中的作用[J]. 实验动物与比较医学, 2014, 34(2):107-112. [11] Kee JY, Han YH, Kim DS, et al.Inhibitory effect of quercetin on colorectal lung metastasis through inducing apoptosis, and suppression of metastatic ability[J]. Phytomedicine, 2016, 23(13):1680-1690. [12] Suganthy N, Devi KP, Nabavi SF, et al.Bioactive effects of quercetin in the central nervous system: focusing on the mechanisms of actions[J]. Biomed Pharmacother, 2016, 84: 892-908. [13] Bhaskar S, Sudhakaran PR, Helen A, et al.Quercetin attenuates atherosclerotic inflammation and adhesion molecule expression by modulating TLR-NF-κB signaling pathway[J]. Cell Immunol, 2016, 310:131-140. [14] Porras D, Nistal E, Martínez-Flórez S, et al.Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation[J]. Free Radic Biol Med, 2016, 102:188-202. [15] Liu L, Gao C, Yao P, et al.Quercetin alleviates high-fat diet-induced oxidized low-density lipoprotein accumulation in the liver: implication for autophagy regulation[J]. Biomed Res Int, 2015, 2015:607531. [16] Mohan SK, Veeraraghavan VP, Jainu M.Effect of pioglitazone, quercetin and hydroxy citric acid on extracellular matrix components in experimentally induced non-alcoholic steatohepatitis[J]. Iran J Basic Med Sci, 2015, 18(8):832-836. [17] Sharifnia T, Antoun J, Verriere TG, et al.Hepatic TLR4 signaling in obese NAFLD[J]. Am J Physiol Gastrointest Liver Physiol, 2015, 309(4):G270-G278. [18] Michelotti GA, Machado MV, Diehl AM.NAFLD, NASH and liver cancer[J]. Nat Rev Gastroenterol Hepatol, 2013, 10(11):656-665. [19] Chu-Sook Kim, Yoonhee Kwon, Suck-Young Choe, et al.Quercetin reduces obesity-induced hepatosteatosis by enhancing mitochondrial oxidative metabolism via heme oxygenase-1[J]. Nutr Metab, 2015, 12:33. [20] Surapaneni KM, Vishnu PV, Mallika J, et al.Effect of pioglitazone, quercetin, and hydroxy citric acid on vascular endothelial growth factor messenger RNA (VEGF mRNA) expression in experimentally induced nonalcoholic steatohepatitis (NASH)[J]. Turk J Med Sci, 2015, 45(3): 542-546. |